Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience.

Daniel AlisedaPablo Martí-CruchagaGabriel ZozayaMacarena Rodríguez-FraileJosé I BilbaoAlberto Benito-BoillosAntonio Martínez De La CuestaLuis Lopez-OlaondoFrancisco HidalgoMariano Ponz-SarviséAna ChopiteaJavier Rodríguez RodríguezMercedes IñarrairaeguiJose Ignacio HerreroFernando PardoBruno SangroFernando Rotellar

Published in: Cancers (2023)

Liver resection after RE is safe and feasible with optimal short-term outcomes. Patients diagnosed with unresectable or high biological risk HCC or ICC, treated with RE, and rescued by LR may achieve optimal global and DFS rates. On the other hand, bridging or downstaging strategies to LT with RE in HCC patients show adequate recurrence rates as well as long-term survival.

Keyphrases

end stage renal disease
newly diagnosed
peritoneal dialysis
stem cells
mesenchymal stem cells
bone marrow
patient reported
liver metastases